Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MoneyMouthon May 10, 2021 12:13pm
205 Views
Post# 33165301

RE:Chilled cheese

RE:Chilled cheese the claim that big Pharma has “way more to gain” only happens if they see themselves being able to get this platform to a place of commercialization before patents run out.

Sernova's patent's are good through 2030. That gives us 9 years, maybe less until we have to actually cough up the cash to refile, but nonetheless, that gives quite a lot of time for trials and other developments, so I don't think there is much of a looming threat of patent expiry. In regards to LJ and Cannacord, please explain how they would have any power to suddenly make Sernova unappealing to large pharma? 


 This company went out and got islets through UHN and conformal coatings, but where is the cash needed to put this all together?  Is $30 mil enough? Nuh-uh.

Well according to Sernova, in their most recent MD&A, Developing Conformal Coating and moving it to the clinic will only cost them a combined 4.5 Million. So actually, 30M seems to be plenty. Additionally, I don't believe you can really be "too late" to the diabetes market. The market is massive and is in need of a better treatment, if another company provides immune protection before Sernova, it is not going to kill Sernova's chance of coming to the market with their own technologies. 


I happen to be a big fan of Swiss cheese except for when someone uses it first as their love toy.

How are you enjoying your swiss cheese so far? Not sure if its ready for consumption yet, the probe's still a'pokin. In regards to blindly accepting the CEO/BOD direction, I hope you aren't implying myself. I disliked the Cannacord deal just as much as the rest of you. However, besides the share-price (which as we know can be subject to being battered by emotional retail guys or professional manipulators in their high castles), there actually has been no indication from a pure business/science perspective that there should be any cause for concern. As far as we know, everything is going swimmingly at Sernova. Although some news releases may be light on information, they are always positive and usually spell good things for the company as a whole.

Let’s hope that the horses we bet on are more sophisticated than the folks who might want to take us out.  Otherwise yours, mine and many other’s recent gains will be deleted in short order.

You see I have a problem when people make claims that lack any credence. The numbers speak for themselves. Sernova has been comparing themselves to their peers forever now and noticing the disparity between their valuation and others. I believe this in itself likely creates a floor for the valuation in which Sernova would like to achieve. I think Sernova is aware of the value of their technologies. I just can't see them undercutting the market value of the company again especially when it's in terms of actually collaborations with a dollar price attached. I think Dr. Toleikis has begun to assemble the right group of people to help advise him on any upcoming opportunities. I think these people have our best interest in mind and would want to protect our recent gains. Why? because it's their gains too.

Enjoy your cheese, sir.
 

<< Previous
Bullboard Posts
Next >>